CA Atra 10 (All-Trans Retinoic Acid) | For Acute Promyelocytic Leukemia (APL) Management
CA Atra 10 contains all-trans retinoic acid (ATRA), also known as tretinoin. It is used in the treatment of acute promyelocytic leukaemia (APL), a type of blood cancer. It helps immature blood cells develop into more mature cells as part of specialist treatment.
Product Overview
CA Atra 10 Softgel Capsule contains tretinoin 10 mg, also known as all-trans retinoic acid (ATRA). Tretinoin is a retinoid related to vitamin A and is used in the treatment of acute promyelocytic leukaemia (APL), a specific type of blood and bone marrow cancer. The active ingredient is confirmed as tretinoin 10 mg in the product information for CA Atra 10.
What Is CA Atra 10?
CA Atra 10 is an oral softgel capsule designed for use as part of specialist treatment for acute promyelocytic leukaemia. This condition affects the development of certain white blood cells in the bone marrow, causing immature cells called promyelocytes to accumulate. Tretinoin helps these abnormal immature cells develop into more mature cells, supporting the treatment process.
How Does CA Atra 10 Work?
The active ingredient, tretinoin, influences the growth and development of immature blood cells. In acute promyelocytic leukaemia, it encourages abnormal promyelocytes to mature rather than remain in an immature state. This action helps doctors manage the condition and work towards remission as part of an appropriate treatment programme.
Understanding the Active Ingredient
Tretinoin, or all-trans retinoic acid, belongs to the retinoid group of medicines. Although it is related to vitamin A, oral tretinoin used for APL has a specific medical role that differs from topical tretinoin products commonly associated with skin care. CA Atra 10 is an oral softgel capsule intended for specialist-directed treatment, not a topical skin product.
Role in Acute Promyelocytic Leukaemia
Acute promyelocytic leukaemia is a distinct form of acute leukaemia involving abnormal promyelocytes. Treatment with all-trans retinoic acid is an important part of managing this condition. Depending on the patient's diagnosis and treatment plan, tretinoin may be used alongside other medicines, such as arsenic trioxide or chemotherapy. The exact combination depends on specialist assessment and the applicable treatment protocol.
Key Product Information
Product Name: CA Atra 10 Softgel Capsule
Active Ingredient: Tretinoin (All-Trans Retinoic Acid)
Strength: 10 mg per capsule
Dosage Form: Softgel capsule
Medicine Class: Retinoids
Route of Administration: Oral
Main Treatment Area: Acute promyelocytic leukaemia (APL)
Treatment and Administration
CA Atra 10 should be used only under the supervision of a qualified specialist familiar with the treatment of blood disorders. The dose, timing, duration and combination with other medicines depend on the patient's clinical condition and response to treatment. Patients should follow their individual treatment plan and should not change the dose or stop treatment without medical guidance.
Summary
CA Atra 10 Softgel Capsule contains tretinoin 10 mg, a retinoid also known as all-trans retinoic acid. Its main role is to support the treatment of acute promyelocytic leukaemia by encouraging immature abnormal blood cells to mature. Understanding its active ingredient, formulation and role in specialist treatment helps readers identify the product and its intended medical purpose.
Precaution
CA Atra 10 contains tretinoin 10 mg (all-trans retinoic acid). It requires specialist supervision and regular monitoring during treatment.
1. Medical Supervision
Take CA Atra 10 only according to the treating specialist’s instructions. Do not change the dose or stop treatment without medical guidance.
2. Pregnancy and Breastfeeding
Tretinoin can harm an unborn baby. Pregnancy must be avoided during treatment, and breastfeeding is not recommended. Discuss appropriate pregnancy testing and preventive measures with the treating specialist.
3. Liver Function
Regular blood tests may be needed to monitor liver function and help the specialist assess treatment progress.
4. Blood Tests and Monitoring
Routine monitoring of blood counts, cholesterol and triglyceride levels may be required throughout treatment.
5. Allergies
Inform the treating specialist about any known allergy to tretinoin, other retinoids or the capsule ingredients.
6. Other Medicines
Share details of all medicines, vitamins and supplements being taken, particularly vitamin A supplements, other retinoids and tetracycline antibiotics.
Important: CA Atra 10 is an oral medicine for specialist-managed treatment of acute promyelocytic leukaemia (APL). Follow the treatment plan and monitoring schedule provided by the healthcare team.
Usage
CA Atra 10 contains tretinoin 10 mg, also known as all-trans retinoic acid (ATRA). It is used as part of specialist treatment for acute promyelocytic leukaemia (APL). Correct usage helps ensure the medicine is taken according to the individual's treatment plan.
How to Take CA Atra 10
Take the capsule orally according to the treating specialist's instructions.
Follow the recommended dose and timing carefully.
Swallow the capsule as directed, and do not crush or chew it unless specifically instructed.
Follow the instructions provided with the product regarding food and administration.
Uses
CA Atra 10 contains tretinoin 10 mg, also known as all-trans retinoic acid (ATRA). It is mainly used as part of specialist treatment for acute promyelocytic leukaemia (APL), a type of blood and bone marrow cancer.
1. Treatment of Acute Promyelocytic Leukaemia (APL)
CA Atra 10 helps manage APL by encouraging immature abnormal blood cells to develop into more mature cells.
2. Supports Remission
Tretinoin plays an important role in APL treatment and may help achieve remission when used as part of an appropriate specialist-directed treatment plan.
3. Promotes Blood Cell Maturation
The active ingredient helps regulate the development of abnormal promyelocytes, supporting the treatment of this specific form of leukaemia.
Important: CA Atra 10 is intended for specialist-managed APL treatment. Its use, dose and duration depend on the individual's treatment plan.
Side Effects
CA Atra 10 contains tretinoin 10 mg, also known as all-trans retinoic acid (ATRA). It is used in the treatment of acute promyelocytic leukaemia (APL). Some people may experience unwanted effects during treatment, and regular medical monitoring is important.
Common Effects
Possible side effects of CA Atra 10 include:
Headache
Dry skin and lips
Nausea or vomiting
Stomach discomfort
Bone or joint pain
Fever
Tiredness
Changes in skin appearance
The severity and duration of these effects can vary from person to person.
FAQs
1. What is CA Atra 10 used for?
CA Atra 10 contains tretinoin and is used to treat acute promyelocytic leukaemia (APL), a type of blood and bone marrow cancer.
2. What is the active ingredient in CA Atra 10?
The active ingredient is tretinoin 10 mg, also known as all-trans retinoic acid (ATRA).
3. How does CA Atra 10 work?
It helps immature abnormal blood cells develop into more mature cells as part of APL treatment.
4. How should CA Atra 10 be taken?
Take it orally according to the treating specialist's instructions. The dose depends on the individual treatment plan.
5. Can CA Atra 10 be taken with other medicines?
Some medicines and supplements may interact with tretinoin. Inform the treating specialist about all products being used.
6. Does CA Atra 10 require regular monitoring?
Yes. Blood tests and other checks may be needed to monitor treatment response and overall health.
7. Is CA Atra 10 the same as topical tretinoin?
No. CA Atra 10 is an oral capsule used for specialist-managed APL treatment, whereas topical tretinoin products are applied to the skin for different purposes.
8. Can CA Atra 10 be stopped once symptoms improve?
Do not stop or change treatment without guidance from the treating specialist. The treatment duration depends on the prescribed clinical plan.
Interactions
CA Atra 10 contains tretinoin 10 mg (all-trans retinoic acid). Certain medicines, vitamins, and supplements may affect its safety or increase the risk of unwanted effects. Inform the treating specialist about all products being used before starting treatment.
1. Vitamin A Supplements
Taking additional vitamin A with tretinoin may increase the risk of retinoid-related effects. Discuss all vitamin supplements with the treating specialist.
2. Other Retinoid Medicines
Medicines containing isotretinoin, acitretin, or other retinoids may increase the risk of unwanted effects when combined with tretinoin.
3. Tetracycline Antibiotics
Antibiotics such as doxycycline and tetracycline may increase the risk of raised pressure inside the skull when used with tretinoin. The combination requires careful medical review.
4. Medicines Affecting Liver Function
Some medicines can affect liver function or change how the body responds to treatment. Share a complete list of current medicines with the treating specialist.
5. Herbal Products and Supplements
Herbal remedies, nutritional supplements, and non-prescription products may also affect treatment. Check with the healthcare team before adding any new product.
6. Alcohol
Discuss alcohol consumption with the treating specialist, particularly because liver function and blood fat levels may require monitoring during treatment.
Important: Do not start, stop, or combine medicines on your own while taking CA Atra 10. The treating specialist can review potential interactions and recommend appropriate monitoring.
| Manufacturer | : | Jenome Biophar |
| Equivalent Brand | : | Vesanoid |
| Generic Search | : | (All-trans Retinoic Acid 10mg) |
Latest Products
